Eli Lilly & Co (LLY) Ratios
Eli Lilly & Co Ratios
MX:LLY's free cash flow for Q3 2026 was $8.22B. For the 2026 fiscal year, MX:LLY's free cash flow was decreased by $-3.18B and operating cash flow was $11.40B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.58 | 1.15 | 0.94 | 1.05 | 1.23 |
| Quick Ratio | 1.19 | 0.89 | 0.73 | 0.80 | 0.97 |
| Cash Ratio | 0.20 | 0.12 | 0.10 | 0.12 | 0.25 |
| Solvency Ratio | 0.26 | 0.19 | 0.13 | 0.20 | 0.18 |
| Operating Cash Flow Ratio | 0.48 | 0.31 | 0.16 | 0.44 | 0.49 |
| Short-Term Operating Cash Flow Coverage | 10.28 | 1.72 | 0.61 | 5.05 | 4.79 |
| Net Current Asset Value | $ -30.31B | $ -31.70B | $ -27.42B | $ -20.68B | $ -21.20B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.38 | 0.43 | 0.39 | 0.33 | 0.35 |
| Debt-to-Equity Ratio | 1.60 | 2.37 | 2.34 | 1.52 | 1.88 |
| Debt-to-Capital Ratio | 0.62 | 0.70 | 0.70 | 0.60 | 0.65 |
| Long-Term Debt-to-Capital Ratio | 0.61 | 0.67 | 0.63 | 0.58 | 0.63 |
| Financial Leverage Ratio | 4.24 | 5.55 | 5.94 | 4.65 | 5.44 |
| Debt Service Coverage Ratio | 10.95 | 2.23 | 0.98 | 4.42 | 3.98 |
| Interest Coverage Ratio | 37.34 | 22.42 | 22.20 | 26.10 | 23.35 |
| Debt to Market Cap | 0.04 | 0.05 | 0.05 | 0.05 | 0.06 |
| Interest Debt Per Share | 48.22 | 38.22 | 28.59 | 17.44 | 18.06 |
| Net Debt to EBITDA | 1.12 | 1.99 | 2.62 | 1.64 | 1.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 83.04% | 81.31% | 79.25% | 76.77% | 74.18% |
| EBIT Margin | 45.56% | 29.88% | 20.63% | 25.01% | 22.94% |
| EBITDA Margin | 48.62% | 33.81% | 25.11% | 30.34% | 28.40% |
| Operating Profit Margin | 45.56% | 38.86% | 31.61% | 30.32% | 28.01% |
| Pretax Profit Margin | 39.48% | 28.15% | 19.21% | 23.85% | 21.74% |
| Net Profit Margin | 31.67% | 23.51% | 15.36% | 21.88% | 19.71% |
| Continuous Operations Profit Margin | 31.67% | 23.51% | 15.36% | 21.88% | 19.71% |
| Net Income Per EBT | 80.21% | 83.51% | 79.95% | 91.75% | 90.68% |
| EBT Per EBIT | 86.65% | 72.45% | 60.76% | 78.66% | 77.59% |
| Return on Assets (ROA) | 18.35% | 13.45% | 8.19% | 12.62% | 11.44% |
| Return on Equity (ROE) | 77.78% | 74.62% | 48.65% | 58.64% | 62.16% |
| Return on Capital Employed (ROCE) | 38.44% | 34.77% | 29.38% | 26.75% | 23.50% |
| Return on Invested Capital (ROIC) | 30.20% | 26.36% | 19.77% | 23.45% | 20.38% |
| Return on Tangible Assets | 20.63% | 15.86% | 10.05% | 16.34% | 15.00% |
| Earnings Yield | 2.14% | 1.52% | 1.00% | 1.80% | 2.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.23 | 3.39 | 3.01 | 3.33 | 3.48 |
| Payables Turnover | 2.05 | 2.61 | 2.73 | 3.43 | 4.38 |
| Inventory Turnover | 0.80 | 1.11 | 1.23 | 1.54 | 1.88 |
| Fixed Asset Turnover | 2.64 | 2.63 | 2.64 | 2.81 | 3.15 |
| Asset Turnover | 0.58 | 0.57 | 0.53 | 0.58 | 0.58 |
| Working Capital Turnover Ratio | 5.26 | 32.21 | -101.88 | 13.29 | 6.76 |
| Cash Conversion Cycle | 389.13 | 296.64 | 284.84 | 240.44 | 215.33 |
| Days of Sales Outstanding | 112.87 | 107.58 | 121.25 | 109.45 | 104.75 |
| Days of Inventory Outstanding | 453.91 | 329.05 | 297.52 | 237.27 | 193.96 |
| Days of Payables Outstanding | 177.65 | 139.99 | 133.94 | 106.29 | 83.38 |
| Operating Cycle | 566.77 | 436.63 | 418.77 | 346.72 | 298.71 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 18.72 | 9.79 | 4.71 | 7.98 | 7.72 |
| Free Cash Flow Per Share | 9.99 | 0.46 | -3.50 | 4.84 | 5.65 |
| Dividend Paid and CapEx Coverage Ratio | 1.27 | 0.67 | 0.37 | 1.16 | 1.45 |
| Capital Expenditure Coverage Ratio | 2.14 | 1.05 | 0.57 | 2.54 | 3.72 |
| Operating Cash Flow Coverage Ratio | 0.40 | 0.26 | 0.17 | 0.47 | 0.44 |
| Operating Cash Flow to Sales Ratio | 0.26 | 0.20 | 0.12 | 0.27 | 0.26 |
| Free Cash Flow Yield | 0.93% | 0.06% | -0.60% | 1.32% | 2.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 46.58 | 65.65 | 100.04 | 55.66 | 47.19 |
| Price-to-Sales (P/S) Ratio | 14.81 | 15.44 | 15.36 | 12.18 | 9.30 |
| Price-to-Book (P/B) Ratio | 36.37 | 48.99 | 48.67 | 32.64 | 29.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 107.56 | 1678.17 | -166.33 | 75.56 | 48.89 |
| Price-to-Operating Cash Flow Ratio | 57.40 | 78.85 | 123.64 | 45.82 | 35.76 |
| Price-to-Earnings Growth (PEG) Ratio | 0.48 | 0.65 | -8.88 | 4.52 | -4.92 |
| Enterprise Value Multiple | 31.57 | 47.65 | 63.81 | 41.77 | 34.38 |
| Enterprise Value | 1.00T | 725.64B | 546.67B | 361.79B | 276.48B |
| EV to EBITDA | 31.57 | 47.65 | 63.81 | 41.77 | 34.38 |
| EV to Sales | 15.35 | 16.11 | 16.02 | 12.68 | 9.76 |
| EV to Free Cash Flow | 111.50 | 1751.49 | -173.44 | 78.64 | 51.32 |
| EV to Operating Cash Flow | 59.50 | 82.29 | 128.93 | 47.69 | 37.54 |
| Tangible Book Value Per Share | 15.72 | 2.59 | -1.09 | -0.53 | -2.55 |
| Shareholders’ Equity Per Share | 29.55 | 15.76 | 11.98 | 11.21 | 9.42 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.16 | 0.20 | 0.08 | 0.09 |
| Revenue Per Share | 72.58 | 50.01 | 37.94 | 30.04 | 29.69 |
| Net Income Per Share | 22.98 | 11.76 | 5.83 | 6.57 | 5.85 |
| Tax Burden | 0.80 | 0.84 | 0.80 | 0.92 | 0.91 |
| Interest Burden | 0.87 | 0.94 | 0.93 | 0.95 | 0.95 |
| Research & Development to Revenue | 0.20 | 0.24 | 0.27 | 0.25 | 0.24 |
| SG&A to Revenue | 0.17 | 0.18 | 0.20 | 0.21 | 0.22 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
| Income Quality | 0.81 | 0.83 | 0.81 | 1.21 | 1.32 |
Currency in USD